Kaymaz C, Tokgöz H. Reply to the Letter to the Editor: “Risk Trajectory and Right Ventricular Adaptation in Selexipag- Based Triple Therapy for Pulmonary Arterial Hypertension”. Anatol J Cardiol. 2026 ;30(5):345-346. doi: 10.14744/AnatolJCardiol.2026.6371.
Kaymaz C, Tokgöz H. Reply to the Letter to the Editor: “Risk Trajectory and Right Ventricular Adaptation in Selexipag- Based Triple Therapy for Pulmonary Arterial Hypertension”. Anatol J Cardiol. 2026;30(5):345-346. doi: 10.14744/AnatolJCardiol.2026.6371
Kaymaz, C., & Tokgöz, H. (2026). Reply to the Letter to the Editor: “Risk Trajectory and Right Ventricular Adaptation in Selexipag- Based Triple Therapy for Pulmonary Arterial Hypertension”. The Anatolian Journal of Cardiology, 30(5), 345-346. https://doi.org/10.14744/AnatolJCardiol.2026.6371
Kaymaz, C., and H. Tokgöz. "Reply to the Letter to the Editor: “Risk Trajectory and Right Ventricular Adaptation in Selexipag- Based Triple Therapy for Pulmonary Arterial Hypertension”." The Anatolian Journal of Cardiology, vol. 30, no. 5, 2026, pp. 345-346. https://doi.org/10.14744/AnatolJCardiol.2026.6371.
Kaymaz, C., H. Tokgöz. 2026. "Reply to the Letter to the Editor: “Risk Trajectory and Right Ventricular Adaptation in Selexipag- Based Triple Therapy for Pulmonary Arterial Hypertension”." The Anatolian Journal of Cardiology 30, no. 5: 345-346. https://doi.org/10.14744/AnatolJCardiol.2026.6371.
